In this way, Vyas et al. used TAT‐FXN fusion protein to deliver human FXN to mitochondria both in cultured patient cells and in a severe mouse model of FRDA, increasing lifespan and cardiac function in the latter 13. Here, FXN is linked to Friedreich ataxia.